ROSELLA: A Phase 3 Study of Relacorilant + Nab-Paclitaxel in Patients with Platinum-Resistant Ovarian Cancer (GOG-3073, ENGOT-ov72, APGOT-Ov10, LACOG-0223, and ANZGOG-2221/2023)

Presented: European Gynaecological Oncology Congress, 26 February 2026, Copenhagen, Denmark

Presenter: Domenica Lorusso, M.D., Ph.D.

Scientific journal publications or scientific congress presentations may include information regarding investigational products or uses.